Related Experiment Video
Updated: Oct 6, 2025

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia/tumorlets]
Karina Patané1, Juan Lucchelli2, Martín Fernandez2
1Servicio de Cirugía Torácica, Hospital de Rehabilitación Respiratoria María Ferrer, Buenos Aires, Argentina.
Diffuse idiopathic hyperplasia of neuroendocrine cells (DIHNE) is a rare lung condition. This study highlights three cases, emphasizing diagnostic challenges and treatment approaches for this uncommon neuroendocrine cell proliferation.
Area of Science:
- Pulmonology
- Endocrinology
- Pathology
Background:
- Diffuse idiopathic hyperplasia of neuroendocrine cells (DIHNE) is an exceptionally rare condition characterized by widespread, unprovoked neuroendocrine cell proliferation.
- While often symptomatic, asymptomatic presentations of DIHNE also occur, posing diagnostic challenges.
Purpose of the Study:
- To report three distinct cases of DIHNE presenting with bilateral pulmonary nodules.
- To discuss the diagnostic difficulties and clinical management of this rare entity.
Main Methods:
- Case series describing three patients (2 female, 1 male) with DIHNE.
- Review of clinical presentations, diagnostic procedures including lung biopsies, and treatment outcomes.
- Analysis of associated symptoms like cough, dyspnea, and paraneoplastic syndromes.
Main Results:
- Two patients diagnosed with DIHNE-tumorlets, one with co-existing typical carcinoid tumor and DIHNE.
- Symptomatic relief achieved with bronchodilators in one case; another experienced severe respiratory failure and paraneoplastic syndromes managed with octreotide.
- One patient remained asymptomatic under follow-up.
Conclusions:
- DIHNE presents a significant diagnostic challenge due to its rarity and varied presentations.
- Lung biopsy is crucial for diagnosing DIHNE in patients with bilateral pulmonary nodules and relevant respiratory symptoms.
- Prompt recognition and management, including addressing potential paraneoplastic phenomena, are vital for patient outcomes.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023